1. Comparing the effectiveness and safety of Sorafenib plus TACE with Apatinib plus TACE for treating patients with unresectable hepatocellular carcinoma: a multicentre propensity score matching study
    Liang Yin et al, 2023, Cancer Imaging CrossRef
  2. Therapeutic Potential of Pigment Epithelium-derived Factor in Cancer
    Sho-ichi Yamagishi et al, 2019, Current Pharmaceutical Design CrossRef
  3. Cordyceps militaris fraction inhibits angiogenesis of hepatocellular carcinoma in vitro and in vivo
    Liyan Song et al, 2020, Pharmacognosy Magazine CrossRef
  4. Meloxicam, a Selective COX-2 Inhibitor, Mediates Hypoxia-Inducible Factor- (HIF-) 1α Signaling in Hepatocellular Carcinoma
    Yinghong Zhou et al, 2020, Oxidative Medicine and Cellular Longevity CrossRef
  5. Peptides derived from growth factors: Exploring their diverse impact from antimicrobial properties to neuroprotection
    Zhang Hai-na et al, 2024, Biomedicine & Pharmacotherapy CrossRef
  6. Pigment Epithelial-Derived Factor in Pancreatic and Liver Cancers—From Inflammation to Cancer
    Sara Pączek et al, 2024, Biomedicines CrossRef
  7. Self-Renewal Inhibition in Breast Cancer Stem Cells: Moonlight Role of PEDF in Breast Cancer
    Carmen Gil-Gas et al, 2023, Cancers CrossRef
  8. Comparing the Effectiveness and Safety of Sorafenib Plus TACE with Apatinib Plus Tace for Treating Patients with Unresectable Hepatocellular Carcinoma: A Multicentre Propensity Score Matching Study
    Kai-Cai Liu et al, SSRN Electronic Journal CrossRef
  9. Pigment epithelium-derived factor and its role in microvascular-related diseases
    Yuzhuo Wang et al, 2022, Biochimie CrossRef
  10. The pathogenesis of liver cancer and the therapeutic potential of bioactive substances
    Song Gao et al, 2022, Frontiers in Pharmacology CrossRef
  11. Effectiveness and Safety of Combination Therapy of Transarterial Chemoembolization and Apatinib for Unresectable Hepatocellular Carcinoma in the Chinese Population: A Meta-Analysis
    Yan Wei et al, 2019, Chemotherapy CrossRef
  12. Prognostic Evaluation for Hepatocellular Carcinoma with Portal Vein Tumor Thrombus Patients Treated with Transarterial Chemoembolization Plus Molecular Targeted Therapies—Development and Validation of the ABPS Score
    Kaicai Liu et al, 2024, Academic Radiology CrossRef
  13. Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1
    Jackie L. Ha et al, 2024, Medical Oncology CrossRef